Table 1. Vaccine and control groups for Ad5hr-SIV trial.
Prime1 | Boost2 | ||||||||
Group | No. of Macaques | Ad5hr-SIV env/rev | Ad5hr-SIV gag | Ad5hr-SIV nef | Ad5hr Vector | SIV gp120 | SIV peptomer | MPL-SE | PBS |
1 | 1 | + | + | + | |||||
2 | 6 | + | + | + | + | ||||
3 | 8 | + | + | + | + | ||||
4 | 8 | + | + | + | + | + | |||
5 | 8 | + | + | + | |||||
6 | 7 | + | + |
Prime includes injections at week 0 (oral and intranasal) and week 12 (intratracheal).
Boost refers to injections at week 24 and 36 (both intramuscular).